3H Medi Solution
☰
About
Company Overview Management Management Philosophy 3H Corporate History
Services
Patient Recruitment & Retention Nursing Services (DCT & Nursing Services) Clinical Research and Patient Insights Healthcare Technologies IoMT Creative Material
Asian Network
Insights
Case Study Blogs
Contact Us
  • About us
    • Company Overview
    • Management
    • Management Philosophy
    • 3H Corporate History
  • Services
    • Patient Recruitment
    • Feasibility Studies
    • Site Selection
    • Patient Retention
    • Information Sharing
    • Technology
    • Evidence
    • Marketing
    • PRC Service
    • ONCOLO
  • Nursing Service
  • Case Study
  • Asian Network
  • Our Blog
  • Contact Us
  • Japan & Asia Clinical
3H Medi Solution
  • About us
    • Company Overview
    • Management
    • Management Philosophy
    • 3H Corporate History
  • Services
    • Patient Recruitment
    • Feasibility Studies
    • Site Selection
    • Patient Retention
    • Information Sharing
    • Technology
    • Evidence
    • Marketing
    • PRC Service
    • ONCOLO
  • Nursing Service
  • Case Study
  • Asian Network
  • Our Blog
  • Contact Us
  • Japan & Asia Clinical

Management

Our Leadership Team

Hirotaka Takizawa
HT
CEO, 3H Medi Solution Inc.
Hirotaka Takizawa

Graduated with a prestigious degree from California State University, USA, he has led cutting-edge system development for insurance and game companies while revolutionizing website creation. His passion for healthcare innovation through IT led him to play a key role in founding CROee in 2005 (now 3H Medi Solution Inc.), developing an advanced patient recruitment system.

In 2009 he became President of the company, strengthening its leadership in patient recruitment and healthcare innovation. As of May 2023, he also serves as President of 3H Medi Solutions Inc. continuing to drive healthcare innovation.

Kenta Kachi
KK
Vice President, 3H Medi Solution Inc.
Kenta Kachi

Kenta Kachi began his career in pharmaceutical clinical development where he identified patient enrolment as a major bottleneck in drug development. In 2015 he joined CROee (now 3H Medi Solution Inc.) to help address this challenge.

He launched the cancer information platform Oncolo and later the rare disease information hub RareS.. In 2018 he moved into health technology, leading the development of the ePRO solution 3H P-Guardian and the clinical consultation system Insight Gateway. He became Director in May 2023.

Daisuke Maki
DM
Head, 3H Life Science Research Institute
Daisuke Maki

Daisuke Maki joined the founding team of CROee Co., Ltd. in 2009 and has supported patient recruitment for more than 300 clinical trials. He has long promoted awareness of patient recruitment in Japan.

In 2017 he launched the PRO Council, bringing together industry leaders to collaborate with regulators and industry bodies. In 2018 he became Director of the 3H Life Science Research Institute, focusing on research aimed at improving human health. His experience as a psychological counsellor also supports clinical development in the CNS domain.

Contact Us

We're currently offline. Send us an email and we'll get back to you, asap.

Send Message
3H Capabilities Download

3H Medi Solution was founded in 2009 and enrolls more than 10,000 subjects per year through their patient recruitment services. Through their flagship website, Seikatsu-Kojo WEB, they have accumulated a database with a patient pool of over 750,000. 3H Medi Solution Global team was established in 2017 in order to better serve global, English-speaking companies with their clinical trials and patient recruitment in Japan. For our Japanese team: Click Here.

CONTACT INFO

  • 3H Medi Solution
  • JRE Minami Ikebukuro Bldg. 2F, 1-13-23 Minami-Ikebukuro, Toshima-Ku, Tokyo, Japan 171-0022
  • +81-3-5953-2108
  • +81-3-5953-1887
  • https://global-3h.com

Fresh from blog

  • The Yield Paradox: Optimizing Recruitment Under Strict Clinical Protocols
  • An insight into the Mental Health Space and 3H’s experience in Paediatrics Major Depression Disorder Study in Japan
  • 3H’s emotional case study of breast cancer patient: Enrolling for Clinical Trial.
  • 3H’s DCT approach for Convenience, Diversity, and Data-Driven Insights.
  • Uchiken: 3H’ Clinical Trial Specialized Nursing Station
  • 3H Medi Solution and Genequest are collaborating to establish a patient registry for inflammatory bowel disease (IBD)

© 2026 · Your Website. Theme by HB-Themes.

  • Home
Project information
Complete the full form below, then view the estimate on the next screen.
Oncology
Cancer-related trials
Rare disease
Orphan conditions
General therapeutic
Standard indications
Please enter a valid patient number.
Please enter a valid email address.
If you would like a detailed breakdown or a multi-country estimate, contact global@3h-ms.co.jp.
Your estimate
Expected Project Cost
-
If you would like a detailed breakdown or a multi-country estimate, contact global@3h-ms.co.jp.
If you would like a detailed breakdown or a multi-country estimate, contact global@3h-ms.co.jp.
© 2026 · 3H Medi Solution · About · Blogs · Capabilities ↓ · Contact Us